LOGO
LOGO

Agios Bolsters Coffers With $1.1 Bln Milestone Payments Following FDA Approval Of Vorasidenib

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024 lt

Agios Pharmaceuticals Inc. (AGIO) is all set to strengthen its cash reserves with over a billion dollars in milestone payments. The news was well received by investors, sending the stock up over 10% to $46 in after-hours trading.What triggered a billion-dollar windfall?The FDA, yesterday, approved Servier's Vorasidenib for adult and pediatric patients 12 years and older with Grade 2 astrocytoma or...

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

Latest Updates on COVID-19